Jan. 4, 2024

The National Institute of Biomedical Imaging and Bioengineering (NIBIB) released its Year in Review, the institute’s top science news of 2023. One review section — Biomedical Imaging Advances — discusses topics including combining ultrasound with artificial intelligence (AI) for cancer detection, an MRI contrast agent that targets hypoxic disease and a helmet with sensors to record brain function.

Also included is an interview between NIBIB and Maryellen Giger, PhD, a professor of radiology at the University of Chicago and the lead contact researcher, about how the Medical Imaging and Data Resource Center (MIDRC) can be used to develop and evaluate AI algorithms. MIDRC has collected images from nearly 55,000 patients, which has helped to create 27 in-house algorithms for the detection, diagnosis, monitoring and prognosis of COVID-19. MIDRC is co-led by investigators from the American College of Radiology® (ACR®), American Association of Physicists in Medicine and the Radiological Society of North America.

The National Institutes of Health (NIH) also recently released its 2023 Research Highlights, divided into three categories: Human Health AdvancesPromising Medical Findings and Basic Research Insights.

ACR will continue to advocate for NIH and biomedical research agencies throughout 2024 to ensure discoveries and research progress.

For more information, contact Katie Grady, ACR Government Affairs Director.


Related ACR News

  • States Still in Session Debate Healthcare Bills

    ACR continues to monitor radiology-specific legislation. With some states still in session, active awareness at the chapter level remains critical.

    Read more
  • Priscilla J. Slanetz, MD, MPH Named RAN Advocate of the Year

    ACR spoke with Dr. Slanetz about her involvement in advocacy and what the Advocate of the Year award means to her.

    Read more
    Dr. Slanetz receiving the RAN Advocate of the Year
  • ACR Leaders Discuss AI with HHS; POTUS AI Plan Released

    Funding for NIH in federal fiscal year (FY) 2026 is uncertain until Congress returns from its August recess.

    Read more